# FDA Inspection 1175500 - Cell Therapies Manufacturing Facility Hackensack University Medical Center - July 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/cell-therapies-manufacturing-facility-hackensack-university-medical-center/17bb722b-d01a-4897-9b29-4cc981a6c3d7
Source feed: FDA_Inspections

> FDA Inspection 1175500 for Cell Therapies Manufacturing Facility Hackensack University Medical Center on July 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175500
- Company Name: Cell Therapies Manufacturing Facility Hackensack University Medical Center
- Inspection Date: 2022-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1175500 - 2022-07-14](https://www.keypedia.com/records/fda_inspections/cell-therapies-manufacturing-facility-hackensack-university-medical-center/990722d7-4827-4c14-b6c4-d53d8b1750dd)

Company: https://www.keypedia.com/companies/cell-therapies-manufacturing-facility-hackensack-university-medical-center/d261378b-79d8-499b-9162-d2aba735ea9b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d